MENU × BUSINESS
Banking And InsuranceCryptocurrencyDigital MarketingErpFood And BeveragesHealthcareLegalMarketing And AdvertisingMedia And EntertainmentMetals And MiningOil And GasRetailTelecom
TECHNOLOGY
Artificial IntelligenceBig DataCloudCyber SecurityE CommerceEducationGaming And VfxIT ServiceMobileNetworkingSAPScience And TechnologySecuritySoftwareStorage
PLATFORM
CiscoDatabaseGoogleIBMJuniperM2MMicrosoftOracleOracleRed Hat
LEADERSHIP
CEO ReviewCompany Review
MAGAZINE
ASIA INDIA
STARTUPS CLIENT SPEAK CONTACT US

The Silicon Review Asia

Natco launches cut-price versions of cancer drug in India

Natco launches cut-price versions of cancer drug in India

Hyderabad-based pharma company Natco Pharma launched a new and cut-price version of ibrutinib which is an anti-cancerous drug under its own brand name called Ibrunat. The patent of this particular drug was held by a company named Pharmacyclics for more than four years in India. But the latter company was acquired by US giant AbbVie. So now, the marketing right for ibrutinib is held by Natco and Johnson & Johnson.

Ibrutinib is used to treat patients with leukemia and other similar types of cancer. It is considered as one of the most used oncogenic drugs. Natco in a recent press meet has announced that the firm is all set to launch the drug under its own brand name by March 2020. It is learned that the Indian drug maker has already dispatched the drug in distribution channels. The Natco drug will cost at approximately INR 38000 per month as opposed to the INR 4 lakh course of the innovator. A patient is expected to take 4 tablets each day.

Natco’s latest move pertaining to the launch of the drug is consistent. Natco's product will be cheaper when compared to the other drugs which were available prior to the market. It is more effective and also is recommended by most of the oncologists in India and other countries too.

YOU MAY ALSO LIKE

Marketing Partnership: NBA, McDonald’s Will Jointly open NBA Experience Zones India

There is good news for all basketball fans in India. Very soon, NBA themed promotions and experience zones will be launched in India. The announcement...

Dunzo to Raise Funds from Google, others

Dunzo, the app which is trying to make life easier for the people upto some extent plans to raise about Rs. 183 crore from different investors which a...

Sapta Shakti Command Will Be Displaying Defence Technology Equipment at Jaipur Military Station

This event is organised with an aim to provide an opportunity where one and all can experience the developments in the field of defence and security-r...

Samsung is All Set to Roll out Its Galaxy A9 Smartphone On November 20

After Samsung unveiled its new Galaxy A9 smartphone in Singapore last month, the company is all set to launch it in India on November 20. In Singapore...

RECOMMENDED